DNA Testing Market Share, Trends And Growth By 2034

Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

What Is the Forecasted Market Size of the DNA Testing Market by 2029?
The dna testing market size has grown rapidly in recent years. It will grow from $17.9 billion in 2024 to $20.04 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to the increasing incidence of chronic diseases, rising demand for precision medicine, rising direct-to-consumer (DTC) testing, rising demand for population genomics, growing forensic investigations, and demand for genetic screening.

The dna testing market size is expected to see rapid growth in the next few years. It will grow to " $30.25 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising incidences of genetic diseases, growing use of DNA diagnostics, growing healthcare infrastructure, growing awareness of disease prevention, rising investment by manufacturers, and increased adoption of companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS), polymerase chain reaction (PCR), preimplantation genetic diagnosis (PGD) in assisted reproductive technologies (art), miniaturization of testing devices, new DNA testing products, and development of novel assays, biomarkers, diagnostic tools, point-of-care testing, and non-invasive prenatal testing (NIPT).

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15358&type=smp

What Are the Significant Market Forces Driving the DNA Testing Market Performance?
The increasing prevalence of genetic disorders is expected to propel the growth of the DNA testing market going forward. Genetic disorders are conditions caused by abnormalities in an individual's DNA, leading to physical or developmental abnormalities. The increasing prevalence of genetic disorders can be attributed to factors such as increased awareness, improved diagnostic techniques, expanded genetic screening, and the rising trend of consanguineous marriages in some populations. DNA testing is increasingly utilized in the diagnosis, prognosis, and treatment decision-making for individuals with genetic disorders, enabling personalized medical care and family planning strategies based on an individual's genetic makeup. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year. Moreover, according to the Centers for Disease Control and Prevention, a US-based government agency, about 6,000 babies are born with Down syndrome in the United States each year, which is about 1 in every 700 babies. Therefore, the increasing prevalence of genetic disorders is driving the DNA testing market.

What Are the Primary Market Segments in the DNA Testing Market?
The dna testingmarket covered in this report is segmented –

1) By Product Type: Equipment; Consumables; Software And Services
2) By Technology: Polymerase Chain Reaction (PCR) Based; In-Situ Hybridization; Microarray; Next-Generation Sequencing (NGS) DNA Diagnosis
3) By Application: Newborn DNA Screening; Pre-Natal DNA Carrier Screening; Oncology Diagnostics And Histopathology; Pre-implantation Diagnosis; Infectious Disease Diagnostics; Pharmacogenomics Diagnostic Testing; Identify Diagnostics And Forensic; Other Applications

Subsegments:
1) By Equipment: DNA Analyzers; PCR (Polymerase Chain Reaction) Machines; Sequencers; Electrophoresis Systems; Other DNA Testing Instruments
2) By Consumables: Reagents And Kits; PCR Consumables (Primers, Probes); DNA Extraction Kits; Sample Collection Devices; Others (DNA Markers, Electrophoresis Gels)
3) By Software: Data Analysis Software; Laboratory Information Management System (LIMS); Genetic Analysis Software; Bioinformatics Software; Other DNA Testing Software Solutions
4) By Services: Testing Services (Genetic Testing, Forensic Testing, Etc.); Data Interpretation Services; Consultation Services (Genetic Counseling); Laboratory Services (Sample Processing, DNA Sequencing Services); Other DNA Testing Services

What Are the Current Trends Influencing the DNA Testing Market?
Major companies operating in the DNA testing market are focused on developing advanced testing solutions such as precancer detection DNA tests, to improve the early diagnosis and treatment of cancer. Precancer detection DNA tests are diagnostic assays designed to identify genetic alterations or biomarkers associated with the early stages of cancer development. For instance, in November 2023, Lucid Diagnostics Inc., a US-based esophageal cancer prevention medical diagnostics company, launched a next-generation EsoGuard Esophageal DNA Test known as EsoGuard 2.0. This advanced esophageal DNA test utilizes molecular techniques and improved sample DNA yields to enhance assay performance and reduce costs. The test involves collecting DNA from esophageal cells using the EsoCheck Cell Collection Device, followed by bisulfite conversion, polymerase chain reaction (PCR) amplification, and next-generation sequencing to identify methylation at specific sites on genes associated with esophageal precancer and cancer. This DNA test provides results indicating the presence or absence of epigenetic changes consistent with esophageal precancer and cancer. It is an essential DNA testing tool in cancer prevention and early detection.

Who Are the Established and Emerging Companies Competing in the DNA Testing Market?
Major companies operating in the DNA testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd., Biocartis SA, CENTOGENE N.V., Everlywell Inc., Atlas Biomed Group Limited, Veritas Genetics

Get the detailed dna testing market report today
https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Which Region Is Expected to Dominate the DNA Testing Market During the Forecast Period?
North America was the largest region in the DNA testing market in 2024. The regions covered in the DNA testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company